Czechia vs Poland: The number of people with susceptibility test result for rifampicin
Czechia
89.51
in 2021
Poland
91.55
in 2021
Czechia rank
68th
Poland rank
65th
The number of people with susceptibility test result for rifampicin over time
- Czechia
- Poland
How they compare
Poland currently reports 91.55 against 89.51 in Czechia, a difference of 2.04.
Across all 5 years both countries report, Poland has been ahead every year.
Czechia ranks 68th and Poland ranks 65th of 146 countries.
Poland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Czechia | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 86.46 | 89.97 | 3.51 | Poland |
| 2020s | 87.15 | 90.9 | 3.74 | Poland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Czechia or Poland?
- Poland, at 91.55 against 89.51 in Czechia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Czechia and Poland?
- 2.04, with Poland ahead.
- How many years of comparable data are there for Czechia and Poland?
- 5 years are reported by both, from 2017 to 2021.
- How do Czechia and Poland rank globally for the number of people with susceptibility test result for rifampicin?
- Czechia ranks 68th and Poland ranks 65th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.